O
Omega Research Group | Omega Research Maitland, LLC
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ozanimod
CVC
IW-1701
Itolizumab
EQ001
Cenicriviroc
PF-05221304
PF-06835375
PF-06865571
Olinciguat
Parent organization
This site is a part of Omega Research Group
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 9 total trials
This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
Active, not recruiting
Crohn Disease
Other: Placebo
Drug: Ozanimod
This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.
Active, not recruiting
Crohn Disease
Drug: Ozanimod
Trial sponsors
C
E
T
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems